The Prevalence of Sjogren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Featuresopen access
- Authors
- Kim, Hyoungyoung; Cho, Soo-Kyung; Kim, Hye Won; Han, Jungyong; Kim, Yujeong; Hwang, Kyung-Gyun; Sung, Yoon-Kyoung
- Issue Date
- Nov-2020
- Publisher
- KOREAN ACAD MEDICAL SCIENCES
- Keywords
- Epidemiology; Prevalence; Sjogren' s Syndrome; Rheumatoid Arthritis
- Citation
- JOURNAL OF KOREAN MEDICAL SCIENCE, v.35, no.45, pp.1 - 11
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- JOURNAL OF KOREAN MEDICAL SCIENCE
- Volume
- 35
- Number
- 45
- Start Page
- 1
- End Page
- 11
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/8848
- DOI
- 10.3346/jkms.2020.35.e369
- ISSN
- 1011-8934
- Abstract
- Background: To estimate the prevalence of Sjogren's syndrome (SS) in patients with rheumatoid arthritis (RA) and to compare the clinical features of RA patients with and without SS.
Methods: We conducted a retrospective study of RA patients who visited a rheumatology clinic in a tertiary referral hospital in Korea between May 20 and July 22, 2016. All patients fulfilled the classification criteria for RA, and the diagnosis of SS was made clinically by rheumatologists and according to the 2002 American-European Consensus Group (AECG), 2012 American College of Rheumatology (ACR), and 2016 ACR/European League Against Rheumatism (EULAR) classification criteria. The prevalence was estimated as the number of SS patients within the total number of RA patients. The disease activity and treatment pattern of RA were compared between patients with and without SS.
Results: Among 827 RA patients, 72 patients (8.7%) were diagnosed with SS by a rheumatologist, though only 60 patients (7.3%) satisfied the 2002 AECG classification criteria for SS. Fifty-two patients (6.3%) and 56 patients (6.8%) fulfilled the 2012 ACR and 2016 ACR/EULAR classification criteria, respectively. The prevalence of SS in RA patients was 10.5%, 17.0%, and 67.6% in rheumatoid factor, antinuclear antibody (>= 1:80), and anti-Ro antibody positive patients, respectively.
Conclusion: The prevalence of SS among RA patients was 8.7% according to rheumatologists' diagnosis. The presence of SS did not affect the treatment patterns of RA patients. However, the autoantibody profiles and demographics of RA patients with SS differed from those of patients without SS.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 치과학교실 > 1. Journal Articles
- 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/8848)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.